nodes	percent_of_prediction	percent_of_DWPC	metapath
Galantamine—CHRFAM7A—corpus luteum—polycystic ovary syndrome	0.0783	0.15	CbGeAlD
Galantamine—CHRNA7—corpus luteum—polycystic ovary syndrome	0.0633	0.121	CbGeAlD
Galantamine—CHRFAM7A—ovarian follicle—polycystic ovary syndrome	0.0613	0.117	CbGeAlD
Galantamine—CHRNA7—ovarian follicle—polycystic ovary syndrome	0.0495	0.0948	CbGeAlD
Galantamine—CHRNA9—embryo—polycystic ovary syndrome	0.0333	0.0637	CbGeAlD
Galantamine—CHRNE—pituitary gland—polycystic ovary syndrome	0.023	0.044	CbGeAlD
Galantamine—CHRNA5—vagina—polycystic ovary syndrome	0.0133	0.0255	CbGeAlD
Galantamine—CHRNG—adipose tissue—polycystic ovary syndrome	0.0114	0.0219	CbGeAlD
Galantamine—Upset stomach—Metformin—polycystic ovary syndrome	0.0113	0.0566	CcSEcCtD
Galantamine—CHRNB4—adrenal gland—polycystic ovary syndrome	0.00988	0.0189	CbGeAlD
Galantamine—CHRNB2—adrenal cortex—polycystic ovary syndrome	0.00866	0.0166	CbGeAlD
Galantamine—CHRNA10—vagina—polycystic ovary syndrome	0.00806	0.0154	CbGeAlD
Galantamine—CYP3A4—urine—polycystic ovary syndrome	0.00786	0.0151	CbGeAlD
Galantamine—CYP2D6—urine—polycystic ovary syndrome	0.00774	0.0148	CbGeAlD
Galantamine—CHRNB2—endometrium—polycystic ovary syndrome	0.00773	0.0148	CbGeAlD
Galantamine—CHRNB2—uterus—polycystic ovary syndrome	0.00712	0.0136	CbGeAlD
Galantamine—CHRNB2—pituitary gland—polycystic ovary syndrome	0.00699	0.0134	CbGeAlD
Galantamine—CHRNB2—adipose tissue—polycystic ovary syndrome	0.00697	0.0133	CbGeAlD
Galantamine—CHRNB2—adrenal gland—polycystic ovary syndrome	0.00625	0.012	CbGeAlD
Galantamine—CHRNA3—adrenal gland—polycystic ovary syndrome	0.00606	0.0116	CbGeAlD
Galantamine—CHRNA1—endocrine gland—polycystic ovary syndrome	0.00589	0.0113	CbGeAlD
Galantamine—Injury—Metformin—polycystic ovary syndrome	0.00585	0.0293	CcSEcCtD
Galantamine—CHRNB1—adipose tissue—polycystic ovary syndrome	0.00584	0.0112	CbGeAlD
Galantamine—CHRNB2—female gonad—polycystic ovary syndrome	0.00583	0.0112	CbGeAlD
Galantamine—CHRNB2—vagina—polycystic ovary syndrome	0.00579	0.0111	CbGeAlD
Galantamine—Renal impairment—Metformin—polycystic ovary syndrome	0.00565	0.0283	CcSEcCtD
Galantamine—Lethargy—Metformin—polycystic ovary syndrome	0.00548	0.0275	CcSEcCtD
Galantamine—Pain in extremity—Metformin—polycystic ovary syndrome	0.00537	0.0269	CcSEcCtD
Galantamine—CHRNA3—endocrine gland—polycystic ovary syndrome	0.00525	0.0101	CbGeAlD
Galantamine—CHRNB1—adrenal gland—polycystic ovary syndrome	0.00524	0.01	CbGeAlD
Galantamine—Dehydration—Metformin—polycystic ovary syndrome	0.005	0.025	CcSEcCtD
Galantamine—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00491	0.0246	CcSEcCtD
Galantamine—CHRNB1—female gonad—polycystic ovary syndrome	0.00489	0.00937	CbGeAlD
Galantamine—CHRNA2—endocrine gland—polycystic ovary syndrome	0.00489	0.00936	CbGeAlD
Galantamine—CHRNB1—vagina—polycystic ovary syndrome	0.00486	0.00931	CbGeAlD
Galantamine—CHRFAM7A—female gonad—polycystic ovary syndrome	0.00457	0.00876	CbGeAlD
Galantamine—ACHE—adrenal gland—polycystic ovary syndrome	0.00454	0.00871	CbGeAlD
Galantamine—CHRNA7—uterus—polycystic ovary syndrome	0.00451	0.00865	CbGeAlD
Galantamine—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00445	0.0223	CcSEcCtD
Galantamine—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00432	0.0216	CcSEcCtD
Galantamine—CHRFAM7A—endocrine gland—polycystic ovary syndrome	0.00425	0.00814	CbGeAlD
Galantamine—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00406	0.0203	CcSEcCtD
Galantamine—CHRNA7—adrenal gland—polycystic ovary syndrome	0.00396	0.00758	CbGeAlD
Galantamine—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00392	0.0196	CcSEcCtD
Galantamine—CHRNA4—adrenal gland—polycystic ovary syndrome	0.0039	0.00748	CbGeAlD
Galantamine—Bradycardia—Metformin—polycystic ovary syndrome	0.00378	0.019	CcSEcCtD
Galantamine—Rhinitis—Metformin—polycystic ovary syndrome	0.00373	0.0187	CcSEcCtD
Galantamine—Hepatitis—Metformin—polycystic ovary syndrome	0.00372	0.0186	CcSEcCtD
Galantamine—CHRNA7—female gonad—polycystic ovary syndrome	0.00369	0.00707	CbGeAlD
Galantamine—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00366	0.0183	CcSEcCtD
Galantamine—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00365	0.0183	CcSEcCtD
Galantamine—Eye disorder—Metformin—polycystic ovary syndrome	0.00347	0.0174	CcSEcCtD
Galantamine—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00345	0.0173	CcSEcCtD
Galantamine—Flushing—Metformin—polycystic ovary syndrome	0.00345	0.0173	CcSEcCtD
Galantamine—CHRNA7—endocrine gland—polycystic ovary syndrome	0.00343	0.00658	CbGeAlD
Galantamine—CHRNA4—endocrine gland—polycystic ovary syndrome	0.00339	0.00649	CbGeAlD
Galantamine—Angiopathy—Metformin—polycystic ovary syndrome	0.00337	0.0169	CcSEcCtD
Galantamine—Immune system disorder—Metformin—polycystic ovary syndrome	0.00336	0.0168	CcSEcCtD
Galantamine—Malnutrition—Metformin—polycystic ovary syndrome	0.00324	0.0162	CcSEcCtD
Galantamine—Flatulence—Metformin—polycystic ovary syndrome	0.00319	0.016	CcSEcCtD
Galantamine—Dysgeusia—Metformin—polycystic ovary syndrome	0.00317	0.0159	CcSEcCtD
Galantamine—Muscle spasms—Metformin—polycystic ovary syndrome	0.00311	0.0156	CcSEcCtD
Galantamine—Vision blurred—Metformin—polycystic ovary syndrome	0.00305	0.0153	CcSEcCtD
Galantamine—Tremor—Metformin—polycystic ovary syndrome	0.00303	0.0152	CcSEcCtD
Galantamine—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.003	0.015	CcSEcCtD
Galantamine—Malaise—Metformin—polycystic ovary syndrome	0.00292	0.0146	CcSEcCtD
Galantamine—Syncope—Metformin—polycystic ovary syndrome	0.0029	0.0145	CcSEcCtD
Galantamine—Palpitations—Metformin—polycystic ovary syndrome	0.00286	0.0143	CcSEcCtD
Galantamine—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00284	0.0143	CcSEcCtD
Galantamine—Hypertension—Metformin—polycystic ovary syndrome	0.00279	0.014	CcSEcCtD
Galantamine—BCHE—endometrium—polycystic ovary syndrome	0.00276	0.00529	CbGeAlD
Galantamine—Chest pain—Metformin—polycystic ovary syndrome	0.00275	0.0138	CcSEcCtD
Galantamine—Myalgia—Metformin—polycystic ovary syndrome	0.00275	0.0138	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00274	0.0137	CcSEcCtD
Galantamine—Discomfort—Metformin—polycystic ovary syndrome	0.00272	0.0136	CcSEcCtD
Galantamine—Shock—Metformin—polycystic ovary syndrome	0.0026	0.013	CcSEcCtD
Galantamine—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00259	0.013	CcSEcCtD
Galantamine—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00259	0.013	CcSEcCtD
Galantamine—Skin disorder—Metformin—polycystic ovary syndrome	0.00256	0.0129	CcSEcCtD
Galantamine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00255	0.0128	CcSEcCtD
Galantamine—BCHE—uterus—polycystic ovary syndrome	0.00255	0.00488	CbGeAlD
Galantamine—Anorexia—Metformin—polycystic ovary syndrome	0.00252	0.0126	CcSEcCtD
Galantamine—BCHE—pituitary gland—polycystic ovary syndrome	0.0025	0.00479	CbGeAlD
Galantamine—BCHE—adipose tissue—polycystic ovary syndrome	0.00249	0.00477	CbGeAlD
Galantamine—Hypotension—Metformin—polycystic ovary syndrome	0.00247	0.0124	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00241	0.0121	CcSEcCtD
Galantamine—Paraesthesia—Metformin—polycystic ovary syndrome	0.00237	0.0119	CcSEcCtD
Galantamine—Somnolence—Metformin—polycystic ovary syndrome	0.00235	0.0118	CcSEcCtD
Galantamine—Dyspepsia—Metformin—polycystic ovary syndrome	0.00232	0.0116	CcSEcCtD
Galantamine—Decreased appetite—Metformin—polycystic ovary syndrome	0.0023	0.0115	CcSEcCtD
Galantamine—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00228	0.0114	CcSEcCtD
Galantamine—Fatigue—Metformin—polycystic ovary syndrome	0.00228	0.0114	CcSEcCtD
Galantamine—Constipation—Metformin—polycystic ovary syndrome	0.00226	0.0113	CcSEcCtD
Galantamine—BCHE—adrenal gland—polycystic ovary syndrome	0.00223	0.00428	CbGeAlD
Galantamine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00218	0.0109	CcSEcCtD
Galantamine—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00216	0.0108	CcSEcCtD
Galantamine—Abdominal pain—Metformin—polycystic ovary syndrome	0.00209	0.0105	CcSEcCtD
Galantamine—BCHE—vagina—polycystic ovary syndrome	0.00207	0.00397	CbGeAlD
Galantamine—BCHE—endocrine gland—polycystic ovary syndrome	0.00194	0.00371	CbGeAlD
Galantamine—Asthenia—Metformin—polycystic ovary syndrome	0.00189	0.00949	CcSEcCtD
Galantamine—Diarrhoea—Metformin—polycystic ovary syndrome	0.00181	0.00905	CcSEcCtD
Galantamine—Dizziness—Metformin—polycystic ovary syndrome	0.00175	0.00875	CcSEcCtD
Galantamine—Vomiting—Metformin—polycystic ovary syndrome	0.00168	0.00841	CcSEcCtD
Galantamine—Rash—Metformin—polycystic ovary syndrome	0.00166	0.00834	CcSEcCtD
Galantamine—Dermatitis—Metformin—polycystic ovary syndrome	0.00166	0.00834	CcSEcCtD
Galantamine—Headache—Metformin—polycystic ovary syndrome	0.00165	0.00829	CcSEcCtD
Galantamine—Nausea—Metformin—polycystic ovary syndrome	0.00157	0.00786	CcSEcCtD
Galantamine—CYP2D6—female gonad—polycystic ovary syndrome	0.00138	0.00264	CbGeAlD
Galantamine—CYP3A4—endocrine gland—polycystic ovary syndrome	0.0013	0.0025	CbGeAlD
Galantamine—CYP2D6—endocrine gland—polycystic ovary syndrome	0.00128	0.00246	CbGeAlD
Galantamine—BCHE—Peptide hormone metabolism—IGF1—polycystic ovary syndrome	0.000344	0.00123	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00034	0.00122	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.000339	0.00122	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000331	0.00119	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000331	0.00119	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000326	0.00117	CbGpPWpGaD
Galantamine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000321	0.00115	CbGpPWpGaD
Galantamine—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000317	0.00114	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000309	0.00111	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000307	0.0011	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000301	0.00108	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—INHBB—polycystic ovary syndrome	0.0003	0.00108	CbGpPWpGaD
Galantamine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000299	0.00107	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000295	0.00106	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000295	0.00106	CbGpPWpGaD
Galantamine—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000295	0.00106	CbGpPWpGaD
Galantamine—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000293	0.00105	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—DLG4—polycystic ovary syndrome	0.000292	0.00105	CbGpPWpGaD
Galantamine—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.000292	0.00105	CbGpPWpGaD
Galantamine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000291	0.00105	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000289	0.00104	CbGpPWpGaD
Galantamine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000287	0.00103	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000281	0.00101	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.00027	0.000968	CbGpPWpGaD
Galantamine—ACHE—Metabolism—NMNAT3—polycystic ovary syndrome	0.000269	0.000966	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—RPL37A—polycystic ovary syndrome	0.000269	0.000965	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—INHBB—polycystic ovary syndrome	0.000267	0.00096	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000266	0.000956	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—DLG4—polycystic ovary syndrome	0.000261	0.000936	CbGpPWpGaD
Galantamine—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.00026	0.000934	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000257	0.000921	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000256	0.000919	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000251	0.000901	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000251	0.0009	CbGpPWpGaD
Galantamine—ACHE—Metabolism—LPCAT2—polycystic ovary syndrome	0.000246	0.000883	CbGpPWpGaD
Galantamine—ACHE—Metabolism—SUOX—polycystic ovary syndrome	0.000246	0.000883	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000243	0.000872	CbGpPWpGaD
Galantamine—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000242	0.000869	CbGpPWpGaD
Galantamine—BCHE—Metabolism—NMNAT3—polycystic ovary syndrome	0.00024	0.000861	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—RPL37A—polycystic ovary syndrome	0.00024	0.000861	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000239	0.000857	CbGpPWpGaD
Galantamine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000236	0.000848	CbGpPWpGaD
Galantamine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000236	0.000848	CbGpPWpGaD
Galantamine—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000236	0.000845	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000235	0.000845	CbGpPWpGaD
Galantamine—ACHE—ATF-2 transcription factor network—IL6—polycystic ovary syndrome	0.000233	0.000837	CbGpPWpGaD
Galantamine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000233	0.000837	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000229	0.000822	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ISYNA1—polycystic ovary syndrome	0.000229	0.000821	CbGpPWpGaD
Galantamine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000227	0.000814	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000224	0.000803	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000224	0.000802	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—LHB—polycystic ovary syndrome	0.000222	0.000796	CbGpPWpGaD
Galantamine—CHRNB2—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.00022	0.00079	CbGpPWpGaD
Galantamine—BCHE—Metabolism—SUOX—polycystic ovary syndrome	0.000219	0.000788	CbGpPWpGaD
Galantamine—BCHE—Metabolism—LPCAT2—polycystic ovary syndrome	0.000219	0.000788	CbGpPWpGaD
Galantamine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000217	0.00078	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000217	0.000779	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000217	0.000778	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000212	0.000762	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000212	0.000759	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000209	0.000749	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000209	0.000749	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ISYNA1—polycystic ovary syndrome	0.000204	0.000732	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000202	0.000724	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000199	0.000716	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—IGFBP1—polycystic ovary syndrome	0.000198	0.000711	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000198	0.000711	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—LHB—polycystic ovary syndrome	0.000198	0.00071	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000197	0.000707	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000197	0.000706	CbGpPWpGaD
Galantamine—ACHE—Metabolism—AKR1C2—polycystic ovary syndrome	0.000194	0.000698	CbGpPWpGaD
Galantamine—ACHE—Metabolism—TEAD2—polycystic ovary syndrome	0.000194	0.000698	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000194	0.000696	CbGpPWpGaD
Galantamine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000192	0.000687	CbGpPWpGaD
Galantamine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.00019	0.000684	CbGpPWpGaD
Galantamine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000188	0.000675	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000187	0.000671	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000186	0.000668	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000184	0.000661	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000184	0.000661	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—IGFBP1—polycystic ovary syndrome	0.000177	0.000635	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000177	0.000634	CbGpPWpGaD
Galantamine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000176	0.000632	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000176	0.000632	CbGpPWpGaD
Galantamine—BCHE—Metabolism—TEAD2—polycystic ovary syndrome	0.000173	0.000623	CbGpPWpGaD
Galantamine—BCHE—Metabolism—AKR1C2—polycystic ovary syndrome	0.000173	0.000623	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000167	0.000601	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000167	0.000599	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—LMNA—polycystic ovary syndrome	0.000164	0.00059	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000164	0.000589	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PNPLA2—polycystic ovary syndrome	0.000163	0.000585	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000156	0.00056	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000156	0.000559	CbGpPWpGaD
Galantamine—ACHE—Metabolism—SRD5A1—polycystic ovary syndrome	0.000154	0.000555	CbGpPWpGaD
Galantamine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000154	0.000554	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000154	0.000553	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000153	0.000551	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.00015	0.000539	CbGpPWpGaD
Galantamine—ACHE—Metabolism—STAR—polycystic ovary syndrome	0.000147	0.000529	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—LMNA—polycystic ovary syndrome	0.000147	0.000526	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—GHRL—polycystic ovary syndrome	0.000146	0.000525	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000146	0.000523	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PNPLA2—polycystic ovary syndrome	0.000145	0.000522	CbGpPWpGaD
Galantamine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000142	0.00051	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—ACE—polycystic ovary syndrome	0.000142	0.000509	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000138	0.000496	CbGpPWpGaD
Galantamine—BCHE—Metabolism—SRD5A1—polycystic ovary syndrome	0.000138	0.000495	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000136	0.00049	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—TCF7L2—polycystic ovary syndrome	0.000136	0.000489	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000132	0.000473	CbGpPWpGaD
Galantamine—BCHE—Metabolism—STAR—polycystic ovary syndrome	0.000131	0.000472	CbGpPWpGaD
Galantamine—ACHE—Metabolism—HMMR—polycystic ovary syndrome	0.000131	0.000472	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—GHRL—polycystic ovary syndrome	0.000131	0.000469	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.00013	0.000467	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000129	0.000462	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000129	0.000461	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000127	0.000455	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—ACE—polycystic ovary syndrome	0.000126	0.000454	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000125	0.00045	CbGpPWpGaD
Galantamine—ACHE—Metabolism—HSD3B1—polycystic ovary syndrome	0.000125	0.00045	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000124	0.000445	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000124	0.000444	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—TCF7L2—polycystic ovary syndrome	0.000121	0.000436	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000117	0.000422	CbGpPWpGaD
Galantamine—BCHE—Metabolism—HMMR—polycystic ovary syndrome	0.000117	0.000421	CbGpPWpGaD
Galantamine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000115	0.000413	CbGpPWpGaD
Galantamine—ACHE—Metabolism—LHB—polycystic ovary syndrome	0.000114	0.00041	CbGpPWpGaD
Galantamine—BCHE—Metabolism—HSD3B1—polycystic ovary syndrome	0.000112	0.000401	CbGpPWpGaD
Galantamine—ACHE—Metabolism—HSD3B2—polycystic ovary syndrome	0.000112	0.000401	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000111	0.000397	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	0.00011	0.000396	CbGpPWpGaD
Galantamine—ACHE—Metabolism—AKR1C1—polycystic ovary syndrome	0.000108	0.000388	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000105	0.000376	CbGpPWpGaD
Galantamine—BCHE—Metabolism—LHB—polycystic ovary syndrome	0.000102	0.000366	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000102	0.000365	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	0.000101	0.000362	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	0.000101	0.000362	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.0001	0.00036	CbGpPWpGaD
Galantamine—BCHE—Metabolism—HSD3B2—polycystic ovary syndrome	9.96e-05	0.000358	CbGpPWpGaD
Galantamine—ACHE—Metabolism—SULT2A1—polycystic ovary syndrome	9.96e-05	0.000357	CbGpPWpGaD
Galantamine—BCHE—Metabolism—AKR1C1—polycystic ovary syndrome	9.65e-05	0.000346	CbGpPWpGaD
Galantamine—ACHE—Metabolism—RRM2—polycystic ovary syndrome	9.64e-05	0.000346	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	9.38e-05	0.000337	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	9.35e-05	0.000336	CbGpPWpGaD
Galantamine—ACHE—Metabolism—YAP1—polycystic ovary syndrome	9.29e-05	0.000334	CbGpPWpGaD
Galantamine—ACHE—Metabolism—NAMPT—polycystic ovary syndrome	8.93e-05	0.000321	CbGpPWpGaD
Galantamine—BCHE—Metabolism—SULT2A1—polycystic ovary syndrome	8.88e-05	0.000319	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	8.88e-05	0.000319	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CYP11A1—polycystic ovary syndrome	8.82e-05	0.000317	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—LEP—polycystic ovary syndrome	8.81e-05	0.000316	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	8.76e-05	0.000314	CbGpPWpGaD
Galantamine—BCHE—Metabolism—RRM2—polycystic ovary syndrome	8.6e-05	0.000309	CbGpPWpGaD
Galantamine—ACHE—Metabolism—AKR1C3—polycystic ovary syndrome	8.33e-05	0.000299	CbGpPWpGaD
Galantamine—BCHE—Metabolism—YAP1—polycystic ovary syndrome	8.29e-05	0.000298	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	8.2e-05	0.000294	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CYP17A1—polycystic ovary syndrome	8.2e-05	0.000294	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	8.09e-05	0.00029	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	7.98e-05	0.000286	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	7.98e-05	0.000286	CbGpPWpGaD
Galantamine—BCHE—Metabolism—NAMPT—polycystic ovary syndrome	7.97e-05	0.000286	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	7.92e-05	0.000284	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CYP11A1—polycystic ovary syndrome	7.87e-05	0.000282	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—LEP—polycystic ovary syndrome	7.86e-05	0.000282	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	7.81e-05	0.00028	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—POMC—polycystic ovary syndrome	7.57e-05	0.000272	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—INS—polycystic ovary syndrome	7.52e-05	0.00027	CbGpPWpGaD
Galantamine—BCHE—Metabolism—AKR1C3—polycystic ovary syndrome	7.43e-05	0.000267	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CYP17A1—polycystic ovary syndrome	7.31e-05	0.000263	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—IGF1—polycystic ovary syndrome	7.28e-05	0.000261	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	7.21e-05	0.000259	CbGpPWpGaD
Galantamine—ACHE—Metabolism—TH—polycystic ovary syndrome	7.09e-05	0.000255	CbGpPWpGaD
Galantamine—ACHE—Metabolism—SLC2A4—polycystic ovary syndrome	6.9e-05	0.000248	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—POMC—polycystic ovary syndrome	6.75e-05	0.000242	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—INS—polycystic ovary syndrome	6.71e-05	0.000241	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	6.68e-05	0.00024	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	6.6e-05	0.000237	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	6.6e-05	0.000237	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—IGF1—polycystic ovary syndrome	6.49e-05	0.000233	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CYP19A1—polycystic ovary syndrome	6.49e-05	0.000233	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	6.34e-05	0.000227	CbGpPWpGaD
Galantamine—BCHE—Metabolism—TH—polycystic ovary syndrome	6.33e-05	0.000227	CbGpPWpGaD
Galantamine—BCHE—Metabolism—SLC2A4—polycystic ovary syndrome	6.16e-05	0.000221	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	6.13e-05	0.00022	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	6.11e-05	0.000219	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	6.05e-05	0.000217	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GNAS—polycystic ovary syndrome	5.79e-05	0.000208	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CYP19A1—polycystic ovary syndrome	5.79e-05	0.000208	CbGpPWpGaD
Galantamine—ACHE—Metabolism—NCOR1—polycystic ovary syndrome	5.52e-05	0.000198	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	5.39e-05	0.000193	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CYP1A1—polycystic ovary syndrome	5.23e-05	0.000188	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	5.22e-05	0.000187	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	5.22e-05	0.000187	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GNAS—polycystic ovary syndrome	5.17e-05	0.000185	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	5.14e-05	0.000185	CbGpPWpGaD
Galantamine—BCHE—Metabolism—NCOR1—polycystic ovary syndrome	4.92e-05	0.000177	CbGpPWpGaD
Galantamine—ACHE—Metabolism—MTHFR—polycystic ovary syndrome	4.88e-05	0.000175	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	4.69e-05	0.000168	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CYP1A1—polycystic ovary syndrome	4.67e-05	0.000167	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	4.58e-05	0.000164	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	4.44e-05	0.000159	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	4.37e-05	0.000157	CbGpPWpGaD
Galantamine—BCHE—Metabolism—MTHFR—polycystic ovary syndrome	4.35e-05	0.000156	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	4.14e-05	0.000149	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	4.08e-05	0.000147	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	3.95e-05	0.000142	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PPARG—polycystic ovary syndrome	3.95e-05	0.000142	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	3.95e-05	0.000142	CbGpPWpGaD
Galantamine—ACHE—Metabolism—POMC—polycystic ovary syndrome	3.9e-05	0.00014	CbGpPWpGaD
Galantamine—ACHE—Metabolism—INS—polycystic ovary syndrome	3.88e-05	0.000139	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	3.81e-05	0.000137	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	3.66e-05	0.000131	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	3.62e-05	0.00013	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PPARG—polycystic ovary syndrome	3.53e-05	0.000127	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	3.52e-05	0.000126	CbGpPWpGaD
Galantamine—BCHE—Metabolism—POMC—polycystic ovary syndrome	3.48e-05	0.000125	CbGpPWpGaD
Galantamine—BCHE—Metabolism—INS—polycystic ovary syndrome	3.46e-05	0.000124	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	3.42e-05	0.000123	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	3.36e-05	0.000121	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	3.36e-05	0.000121	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	3.06e-05	0.00011	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	3e-05	0.000108	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—TH—polycystic ovary syndrome	2.91e-05	0.000104	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	2.9e-05	0.000104	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	2.83e-05	0.000102	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	2.67e-05	9.58e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	2.66e-05	9.55e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	2.59e-05	9.28e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	2.49e-05	8.95e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	2.39e-05	8.6e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	2.38e-05	8.53e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	2.36e-05	8.49e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	2.26e-05	8.12e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	2.23e-05	8.02e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	2.2e-05	7.89e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	2.15e-05	7.7e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	2e-05	7.18e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—TH—polycystic ovary syndrome	1.9e-05	6.83e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	1.85e-05	6.64e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	1.74e-05	6.25e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	1.62e-05	5.82e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	1.6e-05	5.74e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—INS—polycystic ovary syndrome	1.59e-05	5.71e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	1.55e-05	5.57e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	1.48e-05	5.31e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	1.4e-05	5.03e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	1.31e-05	4.69e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.06e-05	3.81e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.05e-05	3.75e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.04e-05	3.73e-05	CbGpPWpGaD
